Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | ATM |
Variant | R2138Kfs*8 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ATM R2138Kfs*8 indicates a shift in the reading frame starting at amino acid 2138 and terminating 8 residues downstream causing a premature truncation of the 3056 amino acid Atm protein (UniProt.org). Due to the loss of most known functional domains (UniProt.org), R2138Kfs*8 is predicted to lead to a loss of Atm protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM inact mut ATM R2138Kfs*8 |
Transcript | NM_000051.3 |
gDNA | chr11:g.108320018dupA |
cDNA | c.6412dupA |
Protein | p.R2138Kfs*8 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011542840 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_017017791.1 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_011542844 | chr11:g.(108330362_108330388) | c.(6412_6438) | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_006718843 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_011542843 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_005271562 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_017017789 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_005271561 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
NM_000051 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_017017791 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_017017790 | chr11:g.108320018dupA | c.6412dupA | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
XM_011542844.3 | chr11:g.(108330362_108330388) | c.(6412_6438) | p.R2138Kfs*8 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|